Paratek Pharmaceuticals, Inc(NASDAQ:PRTK) 
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, ...
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-03-24
P
O 1.69
H 1.71
L 1.62
C 1.65
V 465,024
10EMA 1.65
20EMA 1.65
60EMA 1.65
120EMA 1.65
250EMA 1.65